# Therative

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/therative

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.therative.com
- Total disclosed funding: $9M
- Latest round: Series C (Apr 17, 2007)
- Investors on record: 4

## About

Therative is a digital health company focused on enhancing patient engagement through a comprehensive platform that facilitates real-time communication between healthcare providers and patients.Therative specializes in developing innovative solutions for the digital health sector, streamlining the interaction between healthcare practitioners and patients. The company is headquartered in San Francisco, US. Founded by Luiz Da Silva and Peter Scocimara, Therative has raised USD 9.00 mn in Series C funding led by Bessemer Venture Partners, with participation from Band of Angels, Foundation Capital, and RWI Ventures. This funding round occurred on April 17, 2007, and represents the total amount raised by the company to date, subsequently valuing it at USD 29.145 mn.Therative offers a range of innovative solutions tailored to enhance user experience in the digital health sector. Their core product is a comprehensive platform designed to streamline communication between healthcare providers and patients, facilitating real-time health monitoring, appointment scheduling, and patient education. The platform addresses the critical challenge of patient engagement and adherence to treatment plans, ultimately improving health outcomes. Therative serves a diverse client base that includes healthcare institutions, clinics, and individual practitioners across North America and Europe, ensuring a seamless healthcare delivery process.Therative generates revenue primarily through subscription-based models, providing clients access to their platform and its features. This transactional structure allows healthcare facilities and practitioners to integrate their services into operational workflows without upfront costs. Clients typically pay a recurring fee that varies based on the number of users or specific features accessed, allowing for scalability and flexibility for different organizational sizes. The company’s flagship products, including patient engagement tools and an analytics dashboard, are integral to their overall service offering, fostering long-term partnerships and enhancing user retention.Looking ahead, Therative plans to enhance its product offerings by developing additional features focused on patient engagement and health analytics, with potential launches slated for late 2023. The company aims to expand into European markets, specifically targeting Germany and the UK by 2024. The recent Series C funding of USD 9.00 mn will be strategically utilized to support these initiatives, facilitating product development and market entry efforts.

## Funding rounds

- Series C, Apr 17, 2007, $9M — Band of Angels, Foundation Capital, Bessemer Venture Partners, RWI Ventures

## Investors

- Band of Angels (https://capitalatlas.ai/funds/band-of-angels) — Series C
- Foundation Capital (https://capitalatlas.ai/funds/foundation-capital) — Series C
- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Series C
- RWI Ventures (https://capitalatlas.ai/funds/rwi-ventures) — Series C